Literature DB >> 18693244

Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the N terminus in clamp closure.

Komaraiah Palle1, Luca Pattarello, Marié van der Merwe, Carmen Losasso, Piero Benedetti, Mary-Ann Bjornsti.   

Abstract

In eukaryotes, DNA topoisomerase I (Top1) catalyzes the relaxation of supercoiled DNA by a conserved mechanism of transient DNA strand breakage, rotation, and religation. The unusual architecture of the monomeric human enzyme comprises a conserved protein clamp, which is tightly wrapped about duplex DNA, and an extended coiled-coil linker domain that appropriately positions the C-terminal active site tyrosine domain against the Top1 core to form the catalytic pocket. A structurally undefined N-terminal domain, dispensable for enzyme activity, mediates protein-protein interactions. Previously, reversible disulfide bonds were designed to assess whether locking the Top1 clamp around duplex DNA would restrict DNA strand rotation within the covalent Top1-DNA intermediate. The active site proximal disulfide bond in full-length Top1-clamp(534) restricted DNA rotation (Woo, M. H., Losasso, C., Guo, H., Pattarello, L., Benedetti, P., and Bjornsti, M. A. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 13767-13772), whereas the more distal disulfide bond of the N-terminally truncated Topo70-clamp(499) did not (Carey, J. F., Schultz, S. J., Sisson, L., Fazzio, T. G., and Champoux, J. J. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 5640-5645). To assess the contribution of the N-terminal domain to the dynamics of Top1 clamping of DNA, the same disulfide bonds were engineered into full-length Top1 and truncated Topo70, and the activities of these proteins were assessed in vitro and in yeast. Here we report that the N terminus impacts the opening and closing of the Top1 protein clamp. We also show that the architecture of yeast and human Top1 is conserved in so far as cysteine substitutions of the corresponding residues suffice to lock the Top1-clamp. However, the composition of the divergent N-terminal/linker domains impacts Top1-clamp activity and stability in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693244      PMCID: PMC2562070          DOI: 10.1074/jbc.M804826200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein.

Authors:  James F Carey; Sharon J Schultz; Lisa Sisson; Thomas G Fazzio; James J Champoux
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-23       Impact factor: 11.205

2.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

3.  Regions within the N-terminal domain of human topoisomerase I exert important functions during strand rotation and DNA binding.

Authors:  Rikke From Frøhlich; Félicie Faucon Andersen; Ole Westergaard; Anni Hangaard Andersen; Birgitta Ruth Knudsen
Journal:  J Mol Biol       Date:  2004-02-06       Impact factor: 5.469

4.  Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.

Authors:  Paola Fiorani; Alessandro Bruselles; Mattia Falconi; Giovanni Chillemi; Alessandro Desideri; Piero Benedetti
Journal:  J Biol Chem       Date:  2003-08-06       Impact factor: 5.157

Review 5.  Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.

Authors:  Kevin D Corbett; James M Berger
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

6.  Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin.

Authors:  Michael H Woo; John R Vance; Ana R Otero Marcos; Christian Bailly; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

7.  A novel nuclear localization signal in human DNA topoisomerase I.

Authors:  Y Y Mo; C Wang; W T Beck
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

8.  The deubiquitinating enzyme Doa4p protects cells from DNA topoisomerase I poisons.

Authors:  Paola Fiorani; Robert J D Reid; Antonino Schepis; Hervé R Jacquiau; Hong Guo; Padma Thimmaiah; Piero Benedetti; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

Review 9.  Cancer therapeutics in yeast.

Authors:  Mary Ann Bjornsti
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

10.  Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.

Authors:  Michael H Woo; Carmen Losasso; Hong Guo; Luca Pattarello; Piero Benedetti; Mary-Ann Bjornsti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

View more
  5 in total

1.  Free energy calculations reveal rotating-ratchet mechanism for DNA supercoil relaxation by topoisomerase IB and its inhibition.

Authors:  Jeff Wereszczynski; Ioan Andricioaei
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

2.  Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily.

Authors:  Stefan Gajewski; Evan Q Comeaux; Nauzanene Jafari; Nagakumar Bharatham; Donald Bashford; Stephen W White; Robert C A M van Waardenburg
Journal:  J Mol Biol       Date:  2011-12-06       Impact factor: 5.469

3.  Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.

Authors:  Lorenzo Botta; Silvia Filippi; Claudio Zippilli; Silvia Cesarini; Bruno Mattia Bizzarri; Angela Cirigliano; Teresa Rinaldi; Alessandro Paiardini; Diego Fiorucci; Raffaele Saladino; Rodolfo Negri; Pietro Benedetti
Journal:  ACS Med Chem Lett       Date:  2020-04-10       Impact factor: 4.345

4.  Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2.

Authors:  Shang-Min Chou; Ting-Hsiang Huang; Hsiang-Chin Chen; Tsai-Kun Li
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

5.  DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.

Authors:  Christine M Wright; Marié van der Merwe; Amanda H DeBrot; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.